UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2

Journal of general virology, 2021-04, Vol.102 (4)

2021

Volltextzugriff (PDF)

An Investigation of the Effect of Transfected Defective, Ebola Virus Genomes on Ebola Replication

Frontiers in cellular and infection microbiology, 2020-04, Vol.10, p.159-159

2020

Volltextzugriff (PDF)

Susceptibility and Lethality of Western Equine Encephalitis Virus in Balb/c Mice When Infected by the Aerosol Route

Viruses, 2017-06, Vol.9 (7), p.163

2017

Volltextzugriff (PDF)

Aerosol Survival, Disinfection and Formalin Inactivation of Nipah Virus

Viruses, 2022-09, Vol.14 (9), p.2057

2022

Volltextzugriff (PDF)

Haemostatic Changes in Five Patients Infected with Ebola Virus

Viruses, 2019-07, Vol.11 (7), p.647

2019

Volltextzugriff (PDF)

Tumour Necrosis Factor-α, Chemokines, and Leukocyte Infiltrate Are Biomarkers for Pathology in the Brains of Venezuelan Equine Encephalitis (VEEV)-Infected Mice

Viruses, 2023-05, Vol.15 (6), p.1307

2023

Volltextzugriff (PDF)

Comparison of Experimental Middle East Respiratory Syndrome Coronavirus Infection Acquired by Three Individual Routes of Infection in the Common Marmoset

Journal of virology, 2022-02, Vol.96 (4), p.e0173921-e0173921

2022

Volltextzugriff (PDF)

Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type

Journal of clinical microbiology, 2015-10, Vol.53 (10), p.3148-3154

2015

Volltextzugriff (PDF)

Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality

Virology journal, 2019-01, Vol.16 (1), p.2-12, Article 2

2019

Volltextzugriff (PDF)

A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus

Antiviral research, 2011-04, Vol.90 (1), p.1-8

2011

Volltextzugriff (PDF)

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV

Viruses, 2021-11, Vol.13 (11), p.2231

2021

Volltextzugriff (PDF)

Glucosamine-NISV delivers antibody across the blood-brain barrier: Optimization for treatment of encephalitic viruses

Journal of controlled release, 2020-08, Vol.324, p.644-656

2020

Volltextzugriff (PDF)

Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination

Vaccine, 2006-04, Vol.24 (17), p.3440-3445

2006

Volltextzugriff (PDF)

Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

Frontiers in cellular and infection microbiology, 2021-09, Vol.11, p.716436-716436

2021

Volltextzugriff (PDF)

Survival and persistence of Nipah virus in blood and tissue culture media

Emerging microbes & infections, 2019-01, Vol.8 (1), p.1760-1762

2019

Volltextzugriff (PDF)

Survival of Lassa Virus in Blood and Tissue Culture Media and in a Small Particle Aerosol

Pathogens (Basel), 2020-08, Vol.9 (9), p.680

2020

Volltextzugriff (PDF)

Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus

Virology journal, 2009-07, Vol.6 (1), p.118-118, Article 118

2009

Volltextzugriff (PDF)

Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains

Virology journal, 2009-11, Vol.6 (1), p.206-206, Article 206

2009

Volltextzugriff (PDF)

A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge

Virology (New York, N.Y.), 2012-05, Vol.426 (2), p.100-105

2012

Volltextzugriff (PDF)

Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

Frontiers in cellular and infection microbiology, 2021-12, Vol.11, p.813442-813442

2021

Volltextzugriff (PDF)

Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse

Virology (New York, N.Y.), 2014-03, Vol.452, p.324-333

2014

Volltextzugriff (PDF)

A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus

Vaccine, 2010-08, Vol.28 (34), p.5558-5564

2010

Volltextzugriff (PDF)

CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product

Viral immunology, 2008-12, Vol.21 (4), p.451

2008

Volltextzugriff (PDF)

A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48h after airborne challenge

Virology (New York, N.Y.), 2012-05, Vol.426 (2), p.100-105

2012

Volltextzugriff (PDF)

Response of Mycobacterium smegmatis to acid stress

FEMS microbiology letters, 1996-05, Vol.139 (1), p.11-17

1996

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(44)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Animals
(22)
Humans
(18)
Virology
(17)
Mice
(16)
Mice, Inbred Balb C
(11)
Female
(8)
Microbiology
(8)
Venezuelan Equine Encephalitis Virus
(8)
Biological And Medical Sciences
(7)
Disease Models, Animal
(7)
Encephalitis Virus, Venezuelan Equine - Immunology
(7)
Immunology
(7)
Viruses
(6)
Aerosols
(5)
Alphavirus
(5)
Encephalomyelitis, Venezuelan Equine - Prevention & Control
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Health Aspects
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2

An Investigation of the Effect of Transfected Defective, Ebola Virus Genomes on Ebola Replication

Susceptibility and Lethality of Western Equine Encephalitis Virus in Balb/c Mice When Infected by the Aerosol Route

Aerosol Survival, Disinfection and Formalin Inactivation of Nipah Virus

Haemostatic Changes in Five Patients Infected with Ebola Virus

Tumour Necrosis Factor-α, Chemokines, and Leukocyte Infiltrate Are Biomarkers for Pathology in the Brains of Venezuelan Equine Encephalitis (VEEV)-Infected Mice

Comparison of Experimental Middle East Respiratory Syndrome Coronavirus Infection Acquired by Three Individual Routes of Infection in the Common Marmoset

Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type

Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality

A humanised murine monoclonal antibody with broad serogroup specificity protects mice from challenge with Venezuelan equine encephalitis virus

Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV

Glucosamine-NISV delivers antibody across the blood-brain barrier: Optimization for treatment of encephalitic viruses

Boosting with an adenovirus-based vaccine improves protective efficacy against Venezuelan equine encephalitis virus following DNA vaccination

Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

Survival and persistence of Nipah virus in blood and tissue culture media

Survival of Lassa Virus in Blood and Tissue Culture Media and in a Small Particle Aerosol

Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus

Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains

A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge

Corrigendum: Evaluation of the SARS-CoV-2 Inactivation Efficacy Associated With Buffers From Three Kits Used on High-Throughput RNA Extraction Platforms

Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse

A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus

CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product

A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48h after airborne challenge

Response of Mycobacterium smegmatis to acid stress

Suchergebnisse filtern